Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 22 January 2026

Eternal CEO Exit, Ozempic Generic Nod, Waaree Profit Surge: India’s Q3 Results Move Stocks

Eternal CEO Exit, Ozempic Generic Nod, Waaree Profit Surge: India’s Q3 Results Move Stocks

Eternal founder Deepinder Goyal will step down as CEO on Feb. 1, with Blinkit head Albinder Dhindsa taking over. Dr Reddy’s won approval to sell a generic Ozempic in India and plans to launch 12 million semaglutide pens in the first year. Waaree Energies more than doubled its profit, while HPCL and Bank of India also reported higher earnings for the quarter.
22 January 2026
··
India stock market today: Sensex, Nifty snap 3-day slide as Trump eases tariff threat; rupee breaks losing streak

India stock market today: Sensex, Nifty snap 3-day slide as Trump eases tariff threat; rupee breaks losing streak

Sensex rose 0.49% and Nifty 50 gained 0.53% on Thursday, ending a three-day decline after U.S. President Trump eased tariff threats. The rupee closed at 91.63 per dollar, rebounding from a record low. Dr Reddy’s surged 5.2% after regulatory approval for a generic Ozempic, while Eternal fell 2.7%. The Reserve Bank of India conducted over $2 billion in FX swaps to support liquidity.
22 January 2026
··
ASX 200 rebounds as jobs surprise lifts RBA hike bets; Santos leads energy

ASX 200 rebounds as jobs surprise lifts RBA hike bets; Santos leads energy

Australia’s S&P/ASX 200 rose 0.8% to 8,849, snapping a three-day losing streak, as energy and banks advanced but miners fell 1.6%. Santos and South32 each gained about 5%, while Northern Star dropped 8.8% on weak results. The unemployment rate fell to 4.1% and jobs surged by 65,200, lifting rate hike bets. AUSTRAC ordered an external audit of Airwallex over anti-money laundering concerns.
22 January 2026
····
PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares

PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares

PAVmed shares dropped 3.4% to $11.64 in premarket trading Thursday, following a 94.7% surge the previous session after its Lucid Diagnostics unit secured a U.S. Veterans Affairs contract for the EsoGuard test. Lucid shares fell 10.6% premarket. Investors are seeking details on test rollout and volumes. PAVmed recently completed a 1-for-30 reverse stock split to meet Nasdaq requirements.
22 January 2026
··
Sensex Bounce Fades After Trump Tariff U-Turn: Why Nifty Still Can’t Hold 25,300

Sensex Bounce Fades After Trump Tariff U-Turn: Why Nifty Still Can’t Hold 25,300

Indian shares rebounded Thursday, with the Nifty 50 up 0.53% and Sensex gaining 0.49%, after President Trump dropped tariff threats against Europe and Greenland. The rally lost steam as profit-taking and foreign selling weighed, with FIIs net selling ₹1,788 crore. Dr. Reddy’s rose 5.2% on strong earnings, while Eternal fell 2.7% amid quick-commerce sector pressure.
22 January 2026
··
Ubisoft stock dives as restructuring reset and game cancellations hit outlook

Ubisoft stock dives as restructuring reset and game cancellations hit outlook

Ubisoft shares fell 33% after the company announced a major restructuring and canceled six games, cutting its 2026 net bookings forecast to 1.5 billion euros and projecting a 1 billion euro operating loss. The company withdrew guidance for fiscal 2026/27. Trading paused at 4.6 euros per share, valuing Ubisoft at 616 million euros. Investors await further details at a Feb. 12 update.
22 January 2026
·
Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX

Vertex stock jumps 4% as earnings date nears — what traders watch next for VRTX

Vertex Pharmaceuticals shares rose 4.31% to $461.14, extending gains for a third session with trading volume above the 50-day average. The company will report fourth-quarter and full-year 2025 results after the U.S. market closes on Feb. 12, followed by a conference call. Director Bruce I. Sachs received 107.088 deferred stock units, according to a Jan. 15 regulatory filing.
22 January 2026
···
FedEx stock gets a tug-of-war: downgrade meets $350–$355 targets as freight spin-off looms

FedEx stock gets a tug-of-war: downgrade meets $350–$355 targets as freight spin-off looms

Rothschild Redburn downgraded FedEx to Neutral and raised its price target to $317, citing the planned freight spin-off. Argus and Wolfe Research lifted their FedEx price targets to $350 and $355, respectively, while maintaining positive ratings. FedEx shares closed at $306.95, about 3.7% below their 52-week high. The company aims to complete the FedEx Freight spin-off by June 1, 2026.
22 January 2026
·
1 … 234 235 236 237 238 … 1,172

Stock Market Today

AMD stock rebounds 8% after post-earnings slump as payrolls, CPI loom

AMD stock rebounds 8% after post-earnings slump as payrolls, CPI loom

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, rebounding after a 13% plunge earlier in the week on weak guidance and AI competition fears. The Philadelphia semiconductor index rose 5.7% as chip stocks led a broader market rally. Investors are awaiting next week’s U.S. payrolls and inflation data, which could shift rate expectations for tech.
Netflix stock price ends higher as DOJ widens review of Warner deal — what to watch next week

Netflix stock price ends higher as DOJ widens review of Warner deal — what to watch next week

7 February 2026
Netflix shares rose 1.6% to $82.20 Friday as the Justice Department expanded its antitrust review of the company’s planned $82.7 billion Warner Bros Discovery acquisition. A Wall Street Journal report said investigators are probing possible anti-competitive tactics. Director Reed Hastings reported a transfer of 241,944 shares via a family trust, according to an SEC filing.
Go toTop